The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMast Energy. Regulatory News (MAST)

Share Price Information for Mast Energy. (MAST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.325
Bid: 0.30
Ask: 0.35
Change: 0.00 (0.00%)
Spread: 0.05 (16.667%)
Open: 0.325
High: 0.325
Low: 0.325
Prev. Close: 0.325
MAST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bordesley Update

8 Dec 2022 07:00

RNS Number : 9792I
Mast Energy Developments PLC
08 December 2022
 

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

("MED" or "the Company")

 

8 December 2022

 

Mast Energy Developments PLC ("MED" or "the Company")

 

 Bordesley Update

 

Mast Energy Developments PLC, the UK-based multi-asset owner and operator in the rapidly growing Reserve Power market is pleased to announce a further update to its last announcement (see RNS dated 23 August 2022) on its Bordesley peaking power project ("Bordesley" or the "Project") in central Birmingham, which is in early construction stage.

 

The Company has now fully optimised and has been granted a gas connection route and has also received approval from network supplier, Cadent Gas, for the required pressure and volumes of gas to fuel the Project. The specialist energy connection company, Distributed Energy Connections Limited, have been contracted to provide an all-in gas connection design and construction solution.

 

Additionally, the Company has concluded an EPC contract optimisation with Clarke Energy, during which it emerged that replacing the currently planned 2 x 2.5 MW Jenbacher engines with 1 x 4.5 MW Jenbacher engine, will provide significant savings in capital construction costs and improve overall engine output efficiencies. The revised EPC configuration more than compensates for the small reduction in the output generating capacity and most importantly, improves the overall financial feasibility of the Project.

 

With the developments and progress outlined above now in place, the Project's debt funders, Close Brothers (who have signed a capex debt funding term sheet, see RNS dated 20 October 2021), will now resume their due diligence with anticipated financial close targeted during Q1 2023. It should be noted that Close Brothers have already completed a significant portion of their due diligence during late 2021 and early 2022 but paused their process until issues arising from the gas connection route were de-risked to their satisfaction, which has now been successfully done.

 

Following financial close, the Company will expedite the Project's construction and it is anticipated that Bordesley will be fully constructed, commissioned and in revenue generation by Q4 2023, subject to successful completion of the associated funding process outlined above.

 

The Project has already secured a 15-year T-4 Capacity Market contract in April 2022 at an unprecedented price of £30.59 /kW/p.a., which will also contribute significantly to the revenue generation from the Project once in steady-state production. Further, based on the latest independent financial modelling performed by the Company's leading energy markets data consultant, EnAppSys, it is expected that Bordesley will generate an average total annual revenue of c. £1.5m.

 

Pieter Krügel, MED CEO, commented: "We are pleased with the significant progress and developments on Bordesley the past while and most notably that the hurdle to proceed with the Project's capex debt financing process can now be resumed. We are looking forward to financial close which is expected during Q1 2023 and to then expedite the completion of the Project's construction and commissioning during 2023, in order to start generating revenue as soon as possible.

We look forward to providing the market with further updates in due course as we progress."

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please visit www.med.energy or contact:

 

 Pieter Krügel

info@med.energy

Mast Energy Developments Plc

CEO

 Jonathan Critchley & Keith Swann

+44 (0)20 3869 6080

Clear Capital Markets

Joint Broker

 Zainab Slemang van Rijmenant

zainab@lifacommunications.com

Lifa Communications

Investor and Media

Relations Advisor

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBIBDDBDGDGDR
Date   Source Headline
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
26th Apr 20247:00 amRNSBusiness Update
23rd Apr 20242:30 pmRNSHolding(s) in Company TR 1
11th Apr 20247:00 amRNSBusiness Update
7th Mar 20248:06 amRNSQ1 2024 Corporate Presentation
4th Mar 202410:45 amRNSHolding(s) in Company
28th Feb 20247:00 amRNSFunding Partner, Agreement & Proventure Terminated
20th Feb 20241:00 pmRNSTR-1: Standard form notification of major holdings
5th Feb 20241:55 pmRNSTR-1: Standard form notification of major holdings
24th Jan 20243:45 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSMED Binding JVA Progress Update
2nd Jan 20247:00 amRNSMED Binding JVA Completion Update
22nd Dec 20237:00 amRNSMED Binding JVA Completion Update
15th Dec 20237:00 amRNSDirector Loan & PDMR Share Sale
11th Dec 20237:52 amRNSMED Binding JVA Update
11th Dec 20237:00 amRNSMED Binding JVA Completion Update
5th Dec 20234:30 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSMED Binding JVA Completion Update
15th Nov 20233:31 pmRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSMED Binding JVA Interim Payment Update
26th Oct 202310:54 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSMED Binding JVA Completion Update
12th Oct 20232:03 pmRNSHolding(s) in Company
12th Oct 20232:01 pmRNSHolding(s) in Company
12th Oct 20232:00 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSIssue of Equity
22nd Sep 20237:00 amRNSMED Binding JVA Completion Update
1st Sep 20237:00 amRNSMED Binding Joint Venture Completion Update
25th Aug 20237:00 amRNSHalf-year Report
9th Aug 20232:16 pmRNSHolding(s) in Company
4th Aug 20237:00 amRNSMED Binding Joint Venture Completion Update
12th Jul 20231:15 pmRNSJoint Venture
6th Jun 20231:09 pmRNSResult of AGM
23rd May 20232:30 pmRNSIssue of Equity
22nd May 20233:00 pmRNSShares issue
18th May 20237:00 amRNSJV & Investment. New Broker & Loan Reprofiling
16th May 20231:15 pmRNSNotice of AGM
4th May 20237:00 amRNSQ1 Corporate Presentation and Website Update
28th Apr 20237:00 amRNSResults for the year ended 31 December 2022
27th Feb 20237:00 amRNSPyebridge Update
20th Dec 20224:40 pmRNSSecond Price Monitoring Extn
20th Dec 20224:35 pmRNSPrice Monitoring Extension
20th Dec 20222:05 pmRNSSecond Price Monitoring Extn
20th Dec 20222:00 pmRNSPrice Monitoring Extension
16th Dec 20227:00 amRNSPyebridge SPA Deferred Consideration Settlement
15th Dec 20222:00 pmRNSTR-1: Notification of major holdings
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
8th Dec 20227:00 amRNSBordesley Update
17th Nov 20227:00 amRNSCorporate Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.